CN110540938A - Ordered oriented co-immobilized enzyme membrane reactor and preparation method and application thereof - Google Patents
Ordered oriented co-immobilized enzyme membrane reactor and preparation method and application thereof Download PDFInfo
- Publication number
- CN110540938A CN110540938A CN201910618133.8A CN201910618133A CN110540938A CN 110540938 A CN110540938 A CN 110540938A CN 201910618133 A CN201910618133 A CN 201910618133A CN 110540938 A CN110540938 A CN 110540938A
- Authority
- CN
- China
- Prior art keywords
- enzyme
- membrane
- solution
- immobilized
- membrane reactor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 141
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 96
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 96
- 238000002360 preparation method Methods 0.000 title abstract description 11
- 229940088598 enzyme Drugs 0.000 claims abstract description 95
- 238000006243 chemical reaction Methods 0.000 claims abstract description 37
- 108010093096 Immobilized Enzymes Proteins 0.000 claims abstract description 34
- 238000005373 pervaporation Methods 0.000 claims abstract description 33
- 239000004366 Glucose oxidase Substances 0.000 claims abstract description 15
- 108010015776 Glucose oxidase Proteins 0.000 claims abstract description 15
- 229940116332 glucose oxidase Drugs 0.000 claims abstract description 15
- 235000019420 glucose oxidase Nutrition 0.000 claims abstract description 15
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims abstract description 13
- 108030001003 Long-chain-alcohol oxidases Proteins 0.000 claims abstract description 12
- 108010058646 cyclohexanone oxygenase Proteins 0.000 claims abstract description 12
- 102000007698 Alcohol dehydrogenase Human genes 0.000 claims abstract description 11
- 108010021809 Alcohol dehydrogenase Proteins 0.000 claims abstract description 11
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims abstract description 11
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims abstract description 11
- 102000003425 Tyrosinase Human genes 0.000 claims abstract description 11
- 108060008724 Tyrosinase Proteins 0.000 claims abstract description 11
- 238000006555 catalytic reaction Methods 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 8
- 102000004882 Lipase Human genes 0.000 claims abstract description 5
- 108090001060 Lipase Proteins 0.000 claims abstract description 5
- 239000004367 Lipase Substances 0.000 claims abstract description 5
- 238000010523 cascade reaction Methods 0.000 claims abstract description 5
- 235000019421 lipase Nutrition 0.000 claims abstract description 5
- 239000000243 solution Substances 0.000 claims description 100
- 239000013154 zeolitic imidazolate framework-8 Substances 0.000 claims description 40
- MFLKDEMTKSVIBK-UHFFFAOYSA-N zinc;2-methylimidazol-3-ide Chemical compound [Zn+2].CC1=NC=C[N-]1.CC1=NC=C[N-]1 MFLKDEMTKSVIBK-UHFFFAOYSA-N 0.000 claims description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 34
- 239000002033 PVDF binder Substances 0.000 claims description 33
- 229920002981 polyvinylidene fluoride Polymers 0.000 claims description 33
- 239000008367 deionised water Substances 0.000 claims description 30
- 229910021641 deionized water Inorganic materials 0.000 claims description 30
- 239000000843 powder Substances 0.000 claims description 22
- ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Chemical compound [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 claims description 22
- 239000007788 liquid Substances 0.000 claims description 21
- 238000003860 storage Methods 0.000 claims description 18
- 238000001914 filtration Methods 0.000 claims description 15
- 238000013329 compounding Methods 0.000 claims description 12
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 12
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 12
- 239000011259 mixed solution Substances 0.000 claims description 12
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 claims description 12
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 claims description 12
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 12
- 238000005406 washing Methods 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 10
- 239000012466 permeate Substances 0.000 claims description 10
- LXBGSDVWAMZHDD-UHFFFAOYSA-N 2-methyl-1h-imidazole Chemical compound CC1=NC=CN1 LXBGSDVWAMZHDD-UHFFFAOYSA-N 0.000 claims description 9
- 239000012621 metal-organic framework Substances 0.000 claims description 8
- 239000011148 porous material Substances 0.000 claims description 7
- 239000000758 substrate Substances 0.000 claims description 7
- 230000004907 flux Effects 0.000 claims description 6
- 238000004108 freeze drying Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000001132 ultrasonic dispersion Methods 0.000 claims description 6
- 238000001471 micro-filtration Methods 0.000 claims description 5
- 239000002131 composite material Substances 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 239000002105 nanoparticle Substances 0.000 claims description 2
- -1 poly (dimethoxysiloxane Chemical class 0.000 claims description 2
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 230000003197 catalytic effect Effects 0.000 abstract description 3
- 230000002349 favourable effect Effects 0.000 abstract description 2
- 239000013067 intermediate product Substances 0.000 abstract description 2
- 238000000926 separation method Methods 0.000 abstract description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 9
- 239000008103 glucose Substances 0.000 description 9
- 230000009471 action Effects 0.000 description 7
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 5
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 5
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 description 5
- 239000011714 flavin adenine dinucleotide Substances 0.000 description 5
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 description 5
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000012982 microporous membrane Substances 0.000 description 3
- DCWXELXMIBXGTH-QMMMGPOBSA-N phosphonotyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-QMMMGPOBSA-N 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 229910001868 water Inorganic materials 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- YPZRHBJKEMOYQH-UYBVJOGSSA-L FADH2(2-) Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1COP([O-])(=O)OP([O-])(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C(NC(=O)NC2=O)=C2NC2=C1C=C(C)C(C)=C2 YPZRHBJKEMOYQH-UYBVJOGSSA-L 0.000 description 2
- 235000011089 carbon dioxide Nutrition 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011942 biocatalyst Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000002032 cellular defenses Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000019525 primary metabolic process Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000024053 secondary metabolic process Effects 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M21/00—Bioreactors or fermenters specially adapted for specific uses
- C12M21/18—Apparatus specially designed for the use of free, immobilized or carrier-bound enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/08—Flask, bottle or test tube
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/14—Enzymes or microbial cells immobilised on or in an inorganic carrier
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0055—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10)
- C12N9/0057—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10) with oxygen as acceptor (1.10.3)
- C12N9/0059—Catechol oxidase (1.10.3.1), i.e. tyrosinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0073—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1096—Transferases (2.) transferring nitrogenous groups (2.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
- C12N9/20—Triglyceride splitting, e.g. by means of lipase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01001—Alcohol dehydrogenase (1.1.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/03—Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
- C12Y101/03004—Glucose oxidase (1.1.3.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/03—Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
- C12Y101/0302—Long-chain-alcohol oxidase (1.1.3.20)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y110/00—Oxidoreductases acting on diphenols and related substances as donors (1.10)
- C12Y110/03—Oxidoreductases acting on diphenols and related substances as donors (1.10) with an oxygen as acceptor (1.10.3)
- C12Y110/03001—Catechol oxidase (1.10.3.1), i.e. tyrosinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
- C12Y111/01—Peroxidases (1.11.1)
- C12Y111/01007—Peroxidase (1.11.1.7), i.e. horseradish-peroxidase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/13—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen (1.14.13)
- C12Y114/13022—Cyclohexanone monooxygenase (1.14.13.22)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y206/00—Transferases transferring nitrogenous groups (2.6)
- C12Y206/01—Transaminases (2.6.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/01003—Triacylglycerol lipase (3.1.1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
- C12Y301/03001—Alkaline phosphatase (3.1.3.1)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Sustainable Development (AREA)
- Inorganic Chemistry (AREA)
- Clinical Laboratory Science (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
the invention discloses an orderly oriented co-immobilized enzyme membrane reactor and a preparation method and application thereof, based on a pervaporation membrane component, the pervaporation membrane component comprises a pervaporation membrane compounded with a microporous filter membrane, immobilized enzymes of combined enzymes required by reaction are sequentially fixed on the microporous filter membrane according to an enzyme catalysis cascade reaction sequence, the combined enzymes are any one of a combination of horseradish peroxidase and glucose oxidase, a combination of tyrosinase and alkaline phosphatase, a combination of long-chain alcohol oxidase and omega-transaminase and a combination of alcohol dehydrogenase, cyclohexanone monooxygenase and lipase, and are beneficial to improving the catalytic reaction efficiency, the immobilized enzymes are integrated on one microporous filter membrane, and the transfer efficiency of multi-step catalytic intermediate products is improved; reaction and separation are integrated by arranging the microporous filter membrane, so that the reaction balance is favorably moved to a favorable direction; the reaction condition is mild, and the enzyme immobilization method is simpler.
Description
Technical Field
The invention belongs to the technical field of reactors, and particularly relates to an orderly oriented co-immobilized enzyme membrane reactor, and a preparation method and application thereof.
Background
enzymes act as biocatalysts, increasing the rate of a wide range of diverse chemical reactions occurring in the body. It is an indispensable component for a living body to participate in important chemical reaction processes essential to life, such as DNA replication and transcription, protein synthesis, primary and secondary metabolism, signal transduction, and cellular defense mechanisms. Enzymes are widely used in the fields of biocatalysis, biosensing, biomedical devices, and the like. However, the enzyme has problems of low thermal stability, poor stability of organic solvents, high cost, poor reusability, etc., so that its wide application is greatly hindered.
The enzyme immobilization technique is one of effective methods for overcoming the disadvantages of free enzymes, and shows a very good effect in improving the stability of enzymes under storage and reaction conditions. People usually fix the immobilized enzyme on different macromolecular carriers by using an enzyme immobilization technology and then prepare the immobilized enzyme reactor, so that the time of enzyme catalytic reaction can be shortened, and the reusability of enzyme is improved.
disclosure of Invention
The invention aims to overcome the problem of low conversion efficiency of the conventional immobilized enzyme reactor and provide an orderly oriented co-immobilized enzyme membrane reactor.
The second purpose of the invention is to overcome the problem of complex preparation method of the existing immobilized enzyme reactor and provide the preparation method of the ordered oriented co-immobilized enzyme membrane reactor.
the invention also aims to provide application of the orderly oriented co-immobilized multienzyme reactor.
the technical scheme for solving the technical problems is as follows:
An orderly oriented co-immobilized enzyme membrane reactor is based on a pervaporation membrane assembly, wherein the pervaporation membrane assembly comprises a pervaporation membrane compounded with a microporous filter membrane, immobilized enzymes of combined enzymes required by reaction are sequentially immobilized on the microporous filter membrane according to an enzyme catalysis cascade reaction sequence, and the combined enzymes are any one of a combination of horseradish peroxidase and glucose oxidase, a combination of tyrosinase and alkaline phosphatase, a combination of long-chain alcohol oxidase and omega-transaminase and a combination of alcohol dehydrogenase, cyclohexanone monooxygenase and lipase.
preferably, the organic macromolecular carrier of the immobilized enzyme is made of a metal organic framework Material (MOF).
preferably, the metal organic framework Material (MOF) is ZIF-8 nanoparticles.
preferably, the pervaporation membrane is a polydimethoxysiloxane/polyvinylidene fluoride (PDMS/PVDF) composite membrane, the microfiltration membrane is a PVDF membrane, and the immobilized enzyme is fixed on the microfiltration membrane by a dead-end filtration method.
Preferably, the aperture of the PVDF membrane is 1-3 μm, and the fixation amount of all immobilized enzymes on the PVDF membrane per unit area is 0.1-0.5 mg/cm 2.
Preferably, the permeation flux of the orderly oriented co-immobilized enzyme membrane reactor is 21-22 g.m < -2 > h < -1 >.
A preparation method of an ordered oriented co-immobilized enzyme membrane reactor is characterized by comprising the following steps:
First, an immobilized enzyme solution of a combination enzyme is prepared
step 1: respectively dissolving the combined enzyme in deionized water to obtain a plurality of enzyme solutions;
step 2: mixing the multiple enzyme solutions obtained in the step 1 with a mixed solution respectively, reacting for 30min at room temperature, and standing for 3h to obtain multiple reaction solutions, wherein the mixed solution comprises a zinc nitrate solution and a 2-methylimidazole solution;
And step 3: centrifuging the multiple reaction solutions obtained in the step 2 at 6000rpm for 10min, and respectively collecting multiple white powders;
And 4, step 4: respectively washing the multiple kinds of white powder obtained in the step 3 with deionized water for 3 times, respectively dispersing the white powder in the deionized water, freeze-drying, and collecting multiple kinds of immobilized enzymes in the form of white powder;
and 5: putting the various white powders into the deionized water again respectively, and performing ultrasonic dispersion to obtain an immobilized enzyme solution of the combined enzyme;
Second, dead-end filtration, fixation and compounding
Fixing the immobilized enzyme solution of the combined enzyme obtained in the first step on a microporous filter membrane through dead-end filtration in sequence, washing with deionized water at least twice, compounding the microporous filter membrane on a pervaporation membrane, and fixing the pervaporation membrane in a pervaporation membrane component.
Preferably, in the step 1, the concentration of any enzyme solution is (3.0-5.2) g/L; in the step 2, the volume ratio of the zinc nitrate solution to the 2-methylimidazole solution to any enzyme solution is 2: 20: (1-2); the concentration of the zinc nitrate solution is 0.25-0.36mol/L, and the concentration of the 2-methylimidazole solution is 1.11-1.42 mol/L.
the application of the ordered oriented co-immobilized enzyme membrane reactor is based on the ordered oriented co-immobilized enzyme membrane reactor, wherein a liquid storage tank is also arranged on one side of the ordered oriented co-immobilized enzyme membrane reactor, the enzyme membrane reactor is connected with the liquid storage tank through a feed pipe and a feed liquid pump, and the same side of the enzyme membrane reactor is also connected with the liquid storage tank through a first discharge pipe; and a cold trap, a drying tower, a buffer bottle and a vacuum pump are sequentially arranged on the other side of the enzyme membrane reactor, the enzyme membrane reactor is connected with the cold trap through a second discharge pipe, a pump is arranged between the cold trap and the drying tower, and the initial substrate passes through the enzyme membrane reactor which is orderly and directionally co-fixed to collect the permeate.
Specifically, the air pressure at the downstream of the pervaporation membrane module is adjusted by a pump between the cold trap and the drying tower, so that the air pressure difference is generated between the upstream and the downstream of the pervaporation membrane, and after the air pressure is adjusted to a certain pressure, the pervaporation is started: the raw materials in the liquid storage tank are conveyed to one side of the enzyme membrane reactor through the feed pipe by the feed liquid pump, the raw materials move to the other side of the enzyme membrane reactor under the action of air pressure difference, so that the raw materials are subjected to cascade reaction under the action of various immobilized enzymes on the microfiltration membrane, reaction substrates are converted to form products, the products are enriched on the other side of the pervaporation membrane to form permeate, and if the reaction substrates conveyed to the pervaporation membrane module by the feed liquid pump are excessive, then the permeate is returned to the liquid storage tank through the first discharge pipe, and is conveyed to the cold trap through the discharge pipe under the action of the pump, dry ice is arranged in the cold trap and is used for liquefying the permeate to form permeate, and for the gas which cannot be liquefied in time, the drying tower absorbs water vapor, and a buffer bottle is arranged in front of the vacuum pump in order to prevent the gas of the drying tower from entering the vacuum pump under the action of the vacuum pump.
Compared with the prior art, the invention has the beneficial effects that:
The arrangement sequence of the immobilized enzymes is in accordance with the catalytic sequence of the enzyme cascade reaction, which is beneficial to improving the catalytic reaction efficiency, and the immobilized enzymes are integrated on a microporous filter membrane, so that the transfer efficiency of the multi-step catalytic intermediate product is improved; reaction and separation are integrated by arranging the microporous filter membrane, so that the reaction balance is favorably moved to a favorable direction; the reaction condition is mild, and the enzyme immobilization method is simpler.
drawings
FIG. 1 is a schematic structural diagram of the present invention.
FIG. 2 is a schematic diagram of an apparatus for converting glucose.
the labels in the figure are: 1-pervaporation membrane component, 2-microporous filter membrane, 3-pervaporation membrane, 4-enzyme membrane reactor, 5-cold trap, 6-pump, 7-drying tower, 8-buffer bottle, 9-vacuum pump, 10-liquid storage tank and 11-liquid pump.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1:
A preparation method of an orderly oriented co-immobilized enzyme membrane reactor comprises the following steps:
First, an immobilized enzyme solution of a combination enzyme is prepared
Step 1: respectively dissolving 5mg of horseradish peroxidase (HRP) molecules and 5mg of Glucose Oxidase (GOD) molecules in 1mL of deionized water to obtain horseradish peroxidase solution and glucose oxidase solution;
In step 1 of the present invention, the glucose oxidase molecule contains a prosthetic Flavin Adenine Dinucleotide (FAD).
step 2: respectively mixing the horseradish peroxidase (HRP) solution and the Glucose Oxidase (GOD) solution in the step 1 with a mixed solution, reacting for 30min at room temperature, and standing for 3h to obtain 2 reaction solutions, wherein the mixed solution comprises 2-3mL of 0.31 mol/L zinc nitrate solution and 20-21mL of 1.36 mol/L2-methylimidazole solution;
And step 3: centrifuging the 2 reaction solutions obtained in the step 2 at 6000r/min for 10min, and respectively collecting 2 white powders;
And 4, step 4: respectively washing 2 kinds of white powder for 3 times by using deionized water, then respectively dispersing the white powder in the deionized water for freeze drying, and collecting white powdery HRP/ZIF-8 and GOD/ZIF-8;
And 5: and (3) respectively putting the HRP/ZIF-8 and the GOD/ZIF-8 obtained in the step (4) into 10mL of deionized water again, and performing ultrasonic dispersion to obtain an HRP/ZIF-8 solution and a GOD/ZIF-8 solution.
second, dead-end filtration, fixation and compounding
and (2) sequentially filtering the HRP/ZIF-8 solution and the GOD/ZIF-8 solution obtained in the first step through a dead end to fix the solutions on a PVDF membrane (the diameter of the membrane is 55mm, and the pore diameter is 2 um), washing the PVDF membrane twice by using deionized water, compounding the PVDF membrane on the PDMS/PVDF membrane, and fixing the PDMS/PVDF membrane in a pervaporation membrane component to obtain the ordered oriented co-immobilized enzyme membrane reactor.
In the step 2 of the invention, the zinc nitrate solution and the 2-methylimidazole solution are mixed, so that zinc ions and 2-methylimidazole are coordinated to form ZIF-8.
The dead-end filtration method in the second step of the invention comprises the following steps: the immobilized enzyme solution is placed at the upstream of the membrane, under the pushing of pressure difference, water and the immobilized enzyme smaller than the membrane pores penetrate the microporous membrane, and the immobilized enzyme larger than the membrane pores is intercepted by the microporous membrane, so that the immobilized enzyme is fixed on the microporous membrane, which is a conventional technical means in the field.
the composite of the PVDF film and the PDMS/PVDF film can be as follows: coating a layer of adhesive on the PVDF film, and then gluing the PVDF film with the PDMS/PVDF film or other composite methods, which are conventional technical means in the field; as for how to fix the pervaporation membrane in the pervaporation membrane module, it is a routine technical means in the art, and a person skilled in the art can set the pervaporation membrane according to the actual situation.
The enzyme membrane reactor with ordered orientation co-fixation is used for decomposing glucose, a liquid storage tank is further arranged on one side of the enzyme membrane reactor, the enzyme membrane reactor is connected with the liquid storage tank through a feed pipe and a feed liquid pump, and the enzyme membrane reactor is also connected with the liquid storage tank through a first discharge pipe on the same side; the other side of the enzyme membrane reactor is sequentially provided with a cold trap, a drying tower, a buffer bottle and a vacuum pump, the enzyme membrane reactor is connected with the cold trap through a second discharge pipe, a pump is arranged between the cold trap and the drying tower, a proper amount of glucose solution with the concentration of 20 mu mol/L is put into a liquid storage tank, the glucose solution in the liquid storage tank is conveyed to the enzyme membrane reactor by a feed liquid pump to serve as a substrate on one side of a pervaporation membrane, the substrate firstly passes through GOD/ZIF-8 under the action of the pump, the glucose is catalyzed by glucose oxidase to generate oxidation reaction under the action of oxidant FAD to generate gluconic acid, the FAD is reduced into FADH2, then the FADH2 transmits hydrogen to oxygen to form hydrogen peroxide, the hydrogen peroxide returns to the FAD, the hydrogen peroxide is catalyzed by the HRP to generate H2O through continuous enzyme catalysis reaction, the H2O obtains a permeate through the other side of the pervaporation membrane, and enters the cold trap under the action, and dry ice is arranged in the cold trap and is used for liquefying the permeate and collecting the permeate.
The reaction process is as follows:
The reaction was continued for 2h at an osmotic flux of 21.05 g.m-2. h-1 with a converted glucose amount of 2.67. mu. mol.
Example 2:
a preparation method of an orderly oriented co-immobilized enzyme membrane reactor comprises the following steps:
First, an immobilized enzyme solution of a combination enzyme is prepared
Step 1: dissolving 4.5mg of Tyrosinase (TYR) molecules and 4.5mg of alkaline phosphatase (AKP) molecules in 1.2mL of deionized water to obtain a tyrosinase solution and an alkaline phosphatase solution, respectively;
Step 2: respectively mixing the tyrosinase solution and the alkaline phosphatase solution obtained in the step 1 with a mixed solution, reacting at room temperature for 30min, and standing for 3h to obtain 2 reaction solutions, wherein the mixed solution comprises 2-3mL of 0.26 mol/L zinc nitrate solution and 20-21mL of 1.13 mol/L2-methylimidazole solution;
and step 3: centrifuging the 2 reaction solutions obtained in the step 2 at 6000r/min for 10min, and respectively collecting 2 white powders;
And 4, step 4: respectively washing 2 kinds of white powder with deionized water for 3 times, respectively dispersing the white powder in the deionized water for freeze drying, and collecting white powdery TYR/ZIF-8 and AKP/ZIF-8;
and 5: and respectively putting TYR/ZIF-8 and AKP/ZIF-8 into the deionized water again, and performing ultrasonic dispersion to obtain TYR/ZIF-8 solution and AKP/ZIF-8 solution.
Second, dead-end filtration, fixation and compounding
and (2) sequentially filtering the TYR/ZIF-8 solution and the AKP/ZIF-8 solution obtained in the first step through a dead end to fix the solutions on a PVDF membrane (the diameter of the membrane is 55mm, and the pore diameter of the membrane is 3 um), washing the PVDF membrane twice by using deionized water, compounding the PVDF membrane on the PDMS/PVDF membrane, and fixing the PDMS/PVDF membrane in a pervaporation membrane component to obtain the ordered oriented co-immobilized enzyme membrane reactor.
The device for decomposing o-phospho-L-tyrosine by using the enzyme membrane reactor is the same as that in the embodiment 1, and the glucose solution in the storage tank is changed into the o-phospho-L-tyrosine solution, and the reaction process is as follows:
the reaction was continued for 2h at a permeation flux of 21.05 gm-2. h-1, converting the amount of o-phospho-L-tyrosine to 3.03. mu. mol.
Example 3:
a preparation method of an orderly oriented co-immobilized enzyme membrane reactor comprises the following steps:
First, an immobilized enzyme solution of a combination enzyme is prepared
step 1: respectively dissolving 5.2mg of long-chain alcohol oxidase (LCAO) molecules and 5.2mg of omega-transaminase (omega-TA) molecules in 1.5mL of deionized water to obtain long-chain alcohol oxidase (LCAO) solution and omega-transaminase (omega-TA) solution;
Step 2: respectively mixing the long-chain alcohol oxidase solution and the omega-transaminase solution obtained in the step 1 with a mixed solution, reacting for 30min at room temperature, and standing for 3h to obtain 2 reaction solutions, wherein the mixed solution comprises 2-3mL of zinc nitrate solution with the concentration of 0.26 mol/L and 20-21mL of 2-methylimidazole solution with the concentration of 1.13 mol/L;
And step 3: centrifuging the 2 reaction solutions obtained in the step 2 at 6000rpm for 10min, and respectively collecting 2 white powders;
and 4, step 4: respectively washing 2 kinds of white powder for 3 times by using deionized water, then respectively dispersing the white powder in the deionized water for freeze drying, and collecting white powdery LCAO/ZIF-8 and omega-TA/ZIF-8;
And 5: and (4) respectively putting the LCAO/ZIF-8 and the omega-TA/ZIF-8 in the deionized water again, and performing ultrasonic dispersion to obtain an LCAO/ZIF-8 solution and an omega-TA/ZIF-8 solution.
second, dead-end filtration, fixation and compounding
And sequentially filtering and fixing the LCAO/ZIF-8 solution and the omega-TA/ZIF-8 solution obtained in the first step on a PVDF membrane (the diameter of the membrane is 55mm, and the pore diameter is 2 um) through a dead end, washing the membrane twice by using deionized water, then compounding the PVDF membrane on the PDMS/PVDF membrane, and finally fixing the PDMS/PVDF membrane in a pervaporation membrane component to obtain the ordered oriented co-immobilized enzyme membrane reactor.
the device for decomposing the long-chain primary aliphatic alcohol by using the enzyme membrane reactor is the same as that in the embodiment 1, the glucose solution in the storage tank is changed into the long-chain primary aliphatic alcohol solution, and the reaction process is as follows:
the reaction is continued for 2 hours under the condition that the permeation flux is 21.05 g.m < -2 > h < -1 >, and the amount of the converted long-chain primary aliphatic alcohol is 4.03 mu mol.
Example 4:
A preparation method of an orderly oriented co-immobilized enzyme membrane reactor comprises the following steps:
first, an immobilized enzyme solution of a combination enzyme is prepared
Step 1: respectively dissolving 5mg of Alcohol Dehydrogenase (ADH) molecules, 5mg of cyclohexanone monooxygenase (CHMO) molecules and 5mg of lipase (CAL-A) molecules in 1mL of deionized water to obtain an alcohol dehydrogenase solution, a cyclohexanone monooxygenase solution and a lipase solution;
Step 2: respectively mixing the ethanol dehydrogenase solution, the cyclohexanone monooxygenase solution and the omega-transaminase solution obtained in the step 1 with a mixed solution, reacting for 30min at room temperature, and standing for 3h to obtain 3 reaction solutions, wherein the mixed solution comprises 2-3mL of 0.31 mol/L zinc nitrate solution and 20-21mL of 1.36 mol/L2-methylimidazole solution;
And step 3: centrifuging the 3 reaction solutions obtained in the step 2 at 6000rpm for 10min, and respectively collecting 3 white powders;
and 4, step 4: and respectively washing 3 kinds of white powder by deionized water for 3 times, respectively dispersing the white powder in the deionized water for freeze drying, and collecting white powder ADH/ZIF-8, CHMO/ZIF-8 and CAL-A/ZIF-8.
And 5: respectively putting ADH/ZIF-8, CHMO/ZIF-8 and CAL-A/ZIF-8 into deionized water again, and performing ultrasonic dispersion to obtain ADH/ZIF-8 solution, CHMO/ZIF-8 solution and CAL-A/ZIF-8 solution;
second, dead-end filtration, fixation and compounding
And successively fixing the ADH/ZIF-8 solution, the CHMO/ZIF-8 solution and the CAL-A/ZIF-8 solution obtained in the first step on a PVDF membrane (the diameter of the membrane is 55mm, and the pore diameter is 2 um) through dead-end filtration, then washing twice with deionized water, then compounding the PVDF membrane on the PDMS/PVDF membrane, and finally fixing the PDMS/PVDF membrane in a pervaporation membrane module to obtain the ordered oriented co-fixed enzyme membrane reactor.
utilize this enzyme membrane reactor to decompose cyclohexanol, the device of decomposition cyclohexanol is the same with embodiment 1, changes the glucose solution in the storage tank into cyclohexanol solution, and the oligomeric reaction of CAL-A alcohol catalysis caprolactone in aqueous phase again after starting substrate cyclohexanol is continuously produced into cyclic caprolactone through ADH and CHMO , and its reaction sequence is as follows:
The reaction was continued for 2h at a permeation flux of 21.05 gm-2. h-1, giving a converted cyclohexanol content of 4.73. mu. mol.
Claims (9)
1. the enzyme membrane reactor is characterized in that the enzyme membrane reactor is based on a pervaporation membrane assembly, the pervaporation membrane assembly comprises a pervaporation membrane compounded with a microporous filter membrane, immobilized enzymes of combined enzymes required by reactions are sequentially fixed on the microporous filter membrane according to an enzyme catalysis cascade reaction sequence, and the combined enzymes are any one of a combination of horseradish peroxidase and glucose oxidase, a combination of tyrosinase and alkaline phosphatase, a combination of long-chain alcohol oxidase and omega-transaminase and a combination of alcohol dehydrogenase, cyclohexanone monooxygenase and lipase.
2. an ordered oriented co-immobilized enzyme membrane reactor according to claim 1 wherein the organic macromolecular support of the immobilized enzyme is made of metal organic framework Material (MOF).
3. The ordered oriented co-immobilized enzyme membrane reactor of claim 2, wherein the metal organic framework Material (MOF) is ZIF-8 nanoparticles.
4. The ordered oriented co-immobilized enzyme membrane reactor of claim 1, wherein the pervaporation membrane is a poly (dimethoxysiloxane)/polyvinylidene fluoride (PDMS/PVDF) composite membrane, the microfiltration membrane is a PVDF membrane, and the immobilized enzyme is immobilized on the microfiltration membrane by dead-end filtration.
5. the ordered oriented co-immobilized enzyme membrane reactor of claim 4, wherein the pore size of the PVDF membrane is 1-3 μm, and the immobilization amount of all immobilized enzymes per unit area of the PVDF membrane is 0.1-0.5 mg/cm 2.
6. The ordered oriented co-immobilized enzyme membrane reactor of claim 1, wherein the enzyme membrane reactor has a permeate flux of 21 to 22 g-m-2-h "1.
7. The process of any of claims 1-6 wherein the process comprises the steps of:
First, an immobilized enzyme solution of a combination enzyme is prepared
Step 1: respectively dissolving the combined enzyme in deionized water to obtain a plurality of enzyme solutions;
step 2: mixing the multiple enzyme solutions obtained in the step 1 with a mixed solution respectively, reacting for 30min at room temperature, and standing for 3h to obtain multiple reaction solutions, wherein the mixed solution comprises a zinc nitrate solution and a 2-methylimidazole solution;
and step 3: centrifuging the multiple reaction solutions obtained in the step 2 at 6000r/min for 10min, and respectively collecting multiple white powders;
And 4, step 4: washing the multiple kinds of white powder obtained in the step 3 with deionized water for 3 times respectively, dispersing the white powder in the deionized water respectively, freeze-drying, and collecting multiple kinds of immobilized enzymes in the form of white powder;
And 5: putting a plurality of immobilized enzymes into the deionized water again respectively, and performing ultrasonic dispersion to obtain an immobilized enzyme solution of the combined enzyme;
second, dead-end filtration, fixation and compounding
Fixing the immobilized enzyme solution of the combined enzyme obtained in the first step on a microporous filter membrane through dead-end filtration in sequence, washing with deionized water at least twice, compounding the microporous filter membrane on a pervaporation membrane, and fixing the pervaporation membrane in a pervaporation membrane component.
8. the method of claim 7, wherein in step 1, the concentration of any enzyme solution is (3.0-5.2) g/L; in the step 2, the volume ratio of the zinc nitrate solution to the 2-methylimidazole solution to any enzyme solution is 2: 20: (1-2); the concentration of the zinc nitrate solution is 0.25-0.36mol/L, and the concentration of the 2-methylimidazole solution is 1.11-1.42 mol/L.
9. The use of the ordered oriented co-immobilized enzyme membrane reactor of any one of claims 1 to 6, wherein based on the ordered oriented co-immobilized enzyme membrane reactor, a liquid storage tank is further provided on one side of the ordered oriented co-immobilized enzyme membrane reactor, the enzyme membrane reactor is connected with the liquid storage tank through a feed pipe and a feed liquid pump, and the enzyme membrane reactor is also connected with the liquid storage tank through a first discharge pipe on the same side; and a cold trap, a drying tower, a buffer bottle and a vacuum pump are sequentially arranged on the other side of the enzyme membrane reactor, the enzyme membrane reactor is connected with the cold trap through a second discharge pipe, a pump is arranged between the cold trap and the drying tower, and the initial substrate passes through the enzyme membrane reactor which is orderly and directionally co-fixed to collect the permeate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910618133.8A CN110540938A (en) | 2019-07-10 | 2019-07-10 | Ordered oriented co-immobilized enzyme membrane reactor and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910618133.8A CN110540938A (en) | 2019-07-10 | 2019-07-10 | Ordered oriented co-immobilized enzyme membrane reactor and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110540938A true CN110540938A (en) | 2019-12-06 |
Family
ID=68709731
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910618133.8A Pending CN110540938A (en) | 2019-07-10 | 2019-07-10 | Ordered oriented co-immobilized enzyme membrane reactor and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110540938A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111675825A (en) * | 2020-06-09 | 2020-09-18 | 大连工业大学 | Preparation method of microporous membrane attached with trypsin and application of microporous membrane in proteolysis |
CN115475244A (en) * | 2022-09-30 | 2022-12-16 | 浙江理工大学 | Metal organic framework nano composite and preparation method and application thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990015137A1 (en) * | 1989-06-02 | 1990-12-13 | Synfina-Oleofina S.A. | Enzymes immobilised on microporous composite membranes, activated supports prepared therewith, and uses thereof |
JPH0643130A (en) * | 1992-07-24 | 1994-02-18 | Daikin Ind Ltd | Composite type fixing enzyme film |
CN101974509A (en) * | 2010-09-17 | 2011-02-16 | 北京化工大学 | Preparation method of multi-level structure immobilized enzyme |
CN103877871A (en) * | 2014-03-31 | 2014-06-25 | 大连欧科膜技术工程有限公司 | Composite separating membrane and preparation method and application thereof |
-
2019
- 2019-07-10 CN CN201910618133.8A patent/CN110540938A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990015137A1 (en) * | 1989-06-02 | 1990-12-13 | Synfina-Oleofina S.A. | Enzymes immobilised on microporous composite membranes, activated supports prepared therewith, and uses thereof |
JPH0643130A (en) * | 1992-07-24 | 1994-02-18 | Daikin Ind Ltd | Composite type fixing enzyme film |
CN101974509A (en) * | 2010-09-17 | 2011-02-16 | 北京化工大学 | Preparation method of multi-level structure immobilized enzyme |
CN103877871A (en) * | 2014-03-31 | 2014-06-25 | 大连欧科膜技术工程有限公司 | Composite separating membrane and preparation method and application thereof |
Non-Patent Citations (2)
Title |
---|
俞贤达等: "膜催化用膜材料", 《化学进展》 * |
白云岫等: "高分子修饰/无机晶体固定化酶研究进展", 《生物加工过程》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111675825A (en) * | 2020-06-09 | 2020-09-18 | 大连工业大学 | Preparation method of microporous membrane attached with trypsin and application of microporous membrane in proteolysis |
CN111675825B (en) * | 2020-06-09 | 2022-06-24 | 大连工业大学 | Preparation method of microporous membrane attached with trypsin and application of microporous membrane in proteolysis |
CN115475244A (en) * | 2022-09-30 | 2022-12-16 | 浙江理工大学 | Metal organic framework nano composite and preparation method and application thereof |
CN115475244B (en) * | 2022-09-30 | 2023-11-03 | 浙江理工大学 | Metal organic framework nano-composite and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Singhania et al. | Biological upgrading of volatile fatty acids, key intermediates for the valorization of biowaste through dark anaerobic fermentation | |
Sirkar et al. | Membrane in a reactor: a functional perspective | |
Bakonyi et al. | Biohydrogen purification by membranes: an overview on the operational conditions affecting the performance of non-porous, polymeric and ionic liquid based gas separation membranes | |
US8198055B2 (en) | Process for converting syngas to liquid products with microorganisms on two-layer membrane | |
WO2012077697A1 (en) | Method for producing concentrated aqueous sugar solution | |
CN110540938A (en) | Ordered oriented co-immobilized enzyme membrane reactor and preparation method and application thereof | |
Cao et al. | Enhancing bioethanol productivity by a yeast-immobilized catalytically active membrane in a fermentation-pervaporation coupling process | |
CN102000516B (en) | Method for preparing polydimethylsiloxane (PDMS)/polyvinylidene fluoride (PVDF) composite hollow fiber film | |
WO2012077698A1 (en) | Method for producing concentrated aqueous sugar solution | |
Strathmann et al. | Continuous removal of ethanol from bioreactor by pervaporation | |
Serna-Vazquez et al. | Simultaneous production and extraction of bio-chemicals produced from fermentations via pervaporation | |
CN106754259A (en) | A kind of synthesis gas that ferments produces the system and its processing method of alcohols | |
US8828692B2 (en) | Membrane supported bioreactor for conversion of syngas components to liquid products | |
CN111617645A (en) | Preparation method of low-resistance high-selectivity mixed matrix membrane based on hollow MOFs (metal-organic frameworks) material | |
Knozowska et al. | Membrane assisted processing of acetone, butanol, and ethanol (ABE) aqueous streams | |
CN110669663A (en) | Directional fixed enzyme membrane reactor and preparation method and application thereof | |
EP3575279A1 (en) | Method for producing high concentration alcohol | |
CN103420793B (en) | The method of a kind of polyvinylidene difluoride (PVDF)-polydimethylsiloxane composite membrane separation and purification butanols | |
EP3787780B1 (en) | Carbon dioxide separation membrane comprising carbonic anhydrase | |
JPS63503193A (en) | Conversion of alcohols to aldehydes and hydrogen peroxide by substrate- and product-resistant methanol oxidases | |
JP5130811B2 (en) | Process for producing 1,3-propanediol by continuous fermentation | |
JP3241376B2 (en) | Thin film composite ultrafiltration membrane | |
US20020127665A1 (en) | Production of gluconate salts | |
CN113877436A (en) | Preparation method of silicone rubber modified honeycomb MOF nanosheet membrane | |
US11484842B2 (en) | Method and apparatus for in situ product recovery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191206 |